CARDIFF ONCOLOGY, INC. Amortization of Debt Discount (Premium)
CARDIFF ONCOLOGY, INC. (CRDF) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-03-06
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for the quarter ending 2018-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for the quarter ending 2018-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for fiscal 2017 was $113.78K, a 34.54% decline from fiscal 2016.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for fiscal 2016 was $173.80K, a 49.79% decline from fiscal 2015.
- CARDIFF ONCOLOGY, INC. amortization of debt discount (premium) for fiscal 2015 was $346.16K, a 39.13% increase from fiscal 2014.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 6 month as first filed | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 9 month as first filed | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 12 month as first filed | Amortization of Debt Discount (Premium) 152 month | Amortization of Debt Discount (Premium) 155 month | Amortization of Debt Discount (Premium) 158 month | Amortization of Debt Discount (Premium) 161 month | Amortization of Debt Discount (Premium) 164 month | Amortization of Debt Discount (Premium) 167 month | Amortization of Debt Discount (Premium) 170 month | Amortization of Debt Discount (Premium) 173 month | Amortization of Debt Discount (Premium) 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |||||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-06 | |||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 derived: sum of 4 quarters · filed 2019-03-06 | |||||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $45.56K derived: sum of 4 quarters · filed 2019-03-06 | |||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $45.56K derived: sum of 3 quarters · filed 2019-03-06 | $113.78K 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $45.56K derived: sum of 2 quarters · filed 2018-11-07 | $113.78K 10-Q · filed 2018-11-07 | $181.87K derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | $45.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $113.78K 10-Q · filed 2018-08-03 | $181.87K derived: sum of 3 quarters · filed 2018-08-03 | $234.94K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | $68.22K 10-Q · filed 2018-05-08 | $125.01K 10-Q · filed 2017-05-10 | $136.32K derived: sum of 2 quarters · filed 2018-05-08 | $189.38K derived: sum of 3 quarters · filed 2018-05-08 | $148.96K derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2016-12-31 | $68.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $121.16K derived: sum of 2 quarters · filed 2018-02-26 | $80.74K derived: sum of 3 quarters · filed 2018-02-26 | $173.80K 10-K · filed 2018-02-26 | $390.55K 10-K · filed 2017-03-15 | ||||||||||||
| 2016-09-30 | $53.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $12.65K derived: sum of 2 quarters · filed 2017-11-09 | $105.71K 10-Q · filed 2017-11-09 | $266.42K 10-Q · filed 2016-11-09 | $198.84K derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||
| 2016-06-30 | -$40.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $52.64K 10-Q · filed 2017-08-09 | $181.32K 10-Q · filed 2016-08-04 | $145.77K derived: sum of 3 quarters · filed 2017-08-09 | $205.73K derived: sum of 4 quarters · filed 2017-08-09 | ||||||||||||
| 2016-03-31 | $93.06K 10-Q · filed 2017-05-10 | $186.19K derived: sum of 2 quarters · filed 2017-05-10 | $246.15K derived: sum of 3 quarters · filed 2017-05-10 | $314.51K derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||
| 2015-12-31 | $93.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $153.09K derived: sum of 2 quarters · filed 2017-03-15 | $221.44K derived: sum of 3 quarters · filed 2017-03-15 | $346.16K 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | $59.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $128.31K derived: sum of 2 quarters · filed 2016-11-09 | $253.03K 10-Q · filed 2016-11-09 | $405.77K derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-06-30 | $68.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $193.07K 10-Q · filed 2016-08-04 | $345.81K derived: sum of 3 quarters · filed 2017-03-15 | ||||||||||||||
| 2015-03-31 | $124.71K 10-Q · filed 2016-05-10 | $277.45K derived: sum of 2 quarters · filed 2017-03-15 | |||||||||||||||
| 2014-12-31 | $152.74K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $248.80K 10-K · filed 2017-03-15 | |||||||||||||||
| 2014-09-30 | $96.06K 10-Q · filed 2015-11-09 | ||||||||||||||||
| 2014-03-31 | $2.35M 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | $2.35M 10-K · filed 2014-03-17 | ||||||||||||||||
| 2013-09-30 | $2.35M 10-Q · filed 2013-11-14 | ||||||||||||||||
| 2013-06-30 | $2.35M 10-Q · filed 2013-08-14 | ||||||||||||||||
| 2013-03-31 | $2.35M 10-Q · filed 2013-05-14 | ||||||||||||||||
| 2012-12-31 | $2.35M 10-K · filed 2013-04-01 | ||||||||||||||||
| 2012-09-30 | $2.35M 10-Q · filed 2012-11-14 | ||||||||||||||||
| 2012-06-30 | $2.35M 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | $2.35M 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |